000 01305 a2200397 4500
005 20250516042054.0
264 0 _c20111024
008 201110s 0 0 eng d
022 _a1536-4828
024 7 _a10.1097/MPA.0b013e31821fd5cd
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChiu, Hui-Fen
245 0 0 _aStatin use and the risk of pancreatic cancer: a population-based case-control study.
_h[electronic resource]
260 _bPancreas
_cJul 2011
300 _a669-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aCase-Control Studies
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xpharmacology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOdds Ratio
650 0 4 _aPancreatic Neoplasms
_xepidemiology
650 0 4 _aPharmacoepidemiology
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aTaiwan
_xepidemiology
700 1 _aChang, Chih-Ching
700 1 _aHo, Shu-Chen
700 1 _aWu, Trong-Neng
700 1 _aYang, Chun-Yuh
773 0 _tPancreas
_gvol. 40
_gno. 5
_gp. 669-72
856 4 0 _uhttps://doi.org/10.1097/MPA.0b013e31821fd5cd
_zAvailable from publisher's website
999 _c20911154
_d20911154